Organ-on-Chip Market Set to Reach US$631.1 Million by 2029 Amid Rising Demand for Animal-Free Drug Testing
The global organ-on-chip market is witnessing remarkable growth as pharmaceutical and biotechnology companies increasingly adopt advanced alternatives to traditional animal testing models. Valued at US$89.2 million in 2023, the market expanded to US$123.3 million in 2024 and is projected to grow at an impressive CAGR of 38.6% from 2024 to 2029, ultimately reaching US$631.1 million by 2029.
The...
Organ-on-Chip Market Set to Reach US$631.1 Million by 2029 Amid Rising Demand for Animal-Free Drug Testing
The global organ-on-chip market is witnessing remarkable growth as pharmaceutical and biotechnology companies increasingly adopt advanced alternatives to traditional animal testing models. Valued at US$89.2 million in 2023, the market expanded to US$123.3 million in 2024 and is projected to grow at an impressive CAGR of 38.6% from 2024 to 2029, ultimately reaching US$631.1 million by 2029.
The...
Cell Culture Equipment :Fueled by Growth in Biopharmaceutical Production and Cell-Based Therapies
The global cell culture equipment market is projected to grow from USD 8,368.0 million in 2026 to USD 14,187.6 million by 2031, registering a CAGR of 11.1% during the forecast period. The market is witnessing strong momentum, driven by the increasing adoption of cell culture-based therapies, rising production of monoclonal antibodies, and expanding applications in regenerative medicine and...
Immunohistochemistry: Driven by Rising Cancer Diagnostics and Adoption of Standardized Kits
The global Immunohistochemistry (IHC) Market is projected to grow from USD 3.55 billion in 2025 to USD 5.14 billion by 2030, registering a CAGR of 7.6% during the forecast period. Growth is primarily driven by increasing cancer incidence, expanding diagnostic applications, and the rising need for accurate, biomarker-based disease identification.
Browse
794 ...
Oligonucleotide CDMO Market to Hit US$6.73 Billion by 2029 with 21.8% CAGR | Growth and outlook
The global Oligonucleotide CDMO Market, valued at US$2.33 billion in 2023, is forecasted to grow at a robust CAGR of 21.8%, reaching US$2.51 billion in 2024 and an impressive US$6.73 billion by 2029. Rising outsourcing of development and manufacturing to CDMOs and growing focus on precision/personalized medicine are some of the factors driving the market’s...
Drug Discovery Technologies Market to Reach $51.51 Billion by 2030
The global Drug Discovery Technologies Market is projected to grow from USD 30.58 billion in 2025 to USD 51.51 billion by 2030, registering a CAGR of 11.0% during the forecast period. This growth is being propelled by the increasing outsourcing of drug research and development processes, alongside the rising adoption of advanced technologies aimed at improving drug discovery...
Preimplantation Genetic Testing : Driven by IVF Demand and Advances in Genetic Screening
The global Preimplantation Genetic Testing (PGT) Market is projected to grow from USD 690.2 million in 2025 to USD 1,135.0 million by 2030, registering a CAGR of 10.5% during the forecast period. The market is witnessing strong growth due to rising infertility rates, increasing prevalence of genetic disorders, and expanding adoption of assisted reproductive...
Gene Transfer Technologies Market to Reach $5.93 Billion by 2029
The global Gene Transfer Technologies Market is projected to grow from USD 3.73 billion in 2024 to USD 5.93 billion by 2029, registering a CAGR of 9.7% during the forecast period. Market growth is fueled by increasing adoption of personalized medicine, expanding applications in gene therapy, and rising investments in biotechnology and advanced therapeutics
Download...
Single-Use Bioprocessing Market to Reach $33.67 Billion by 2030 | Growth, Trends & Opportunities
The global single-use bioprocessing market is projected to grow from USD 18.01 billion in 2025 to USD 33.67 billion by 2030, registering a CAGR of 13.3% during the forecast period. This rapid expansion is driven by the increasing adoption of single-use technologies among CDMOs and CMOs, rising demand for cost-efficient production, reduced risk of cross-contamination, and lower capital investment requirements.
Market...